Management of Anxiety Disorders
First-line treatments for anxiety disorders include cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs), which should be offered based on symptom severity, patient preference, and treatment availability.
Assessment and Diagnosis
Anxiety disorders are characterized by:
- Excessive worry, fear, or anxiety that is disproportionate to actual threat
- Persistent symptoms (typically lasting 6+ months)
- Significant distress or functional impairment
- Common physical symptoms including palpitations, shortness of breath, and dizziness
Treatment Algorithm
First-Line Treatments
Psychological Interventions
- Cognitive Behavioral Therapy (CBT): Strongest evidence for efficacy across anxiety disorders 1
- Components include: education about anxiety, behavioral goal setting, cognitive restructuring, relaxation techniques, and graduated exposure
- Typically 14 individual sessions over 4 months (60-90 minutes per session)
- Cornerstone technique: graduated exposure to feared stimuli using fear hierarchies
Pharmacotherapy
SNRIs: Alternative first-line medication 2, 5
- Venlafaxine extended-release: Effective alternative if SSRIs not tolerated
Second-Line and Adjunctive Treatments
- Mindfulness-Based Interventions (MBIs): Effective for anxiety symptoms, particularly during active treatment 1
- Yoga: Moderate evidence for anxiety reduction, particularly for breast cancer patients 1
- Relaxation techniques: Including deep breathing, progressive muscle relaxation 1
- Buspirone: 15-30mg daily in divided doses for augmentation 6, 7
- Exercise and physical activity: Structured physical activity programs 1
Treatment Considerations
Initial treatment selection factors:
- Patient preference
- Previous treatment response
- Comorbid conditions
- Access to care
- Cost considerations
Medication management:
Special populations:
Common Pitfalls to Avoid
- Premature discontinuation: Continue treatment for adequate duration (6-12 months after remission)
- Benzodiazepine overuse: Not recommended for routine use due to risk of dependence 5
- Inadequate dosing: Ensure therapeutic doses are reached before concluding treatment failure
- Overlooking comorbidities: Anxiety often co-occurs with depression, substance use disorders, and medical conditions
- Ignoring non-adherence: Regularly assess medication adherence and barriers to treatment
Treatment Outcomes
Success should be measured by:
- Reduction in anxiety symptoms
- Improved interpersonal functioning
- Enhanced quality of life
- Decreased avoidance behaviors
- Return to normal daily activities
For persistent or treatment-resistant anxiety, consider combination therapy (medication plus CBT) or referral to a mental health specialist for more intensive treatment.